The mechanism of action of rivaroxaban – an oral, direct Factor Xa inhibitor – compared with other anticoagulants - Thrombosis Research
Idarucizumab, a Specific Reversal Agent for Dabigatran: Mode of Action, Pharmacokinetics and Pharmacodynamics, and Safety and Efficacy in Phase 1 Subjects - The American Journal of Medicine
The use of dabigatran in general practice - BPJ Issue 38
Direct oral anticoagulants: evidence and unresolved issues - The Lancet
PRADAXA (DABAGATRAN), A New Anticoagulant for Stroke and Embolism Prevention
Implications of Dabigatran, a Direct Thrombin Inhibitor, for Oral Surgery Practice | jcda
Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease | American Society of Nephrology
Christopher Malabanan, Pharm.D., BCPS, CACP Jenny Park, Pharm.D. - ppt download
Mechanism of action of the non-vitamin K antagonist oral anticoagulants... | Download Scientific Diagram
Update on laboratory testing and hemostasis assessment in patients receiving direct oral anticoagulants (DOACs) - ScienceDirect
Dentistry Journal | Free Full-Text | New Direct Oral Anticoagulants (DOAC) and Their Use Today | HTML
New Anticoagulants – 5 Deaths Prompt Dabigatran Safety Advisory in Japan | Earl's View
Frontiers | The Discovery of Dabigatran Etexilate | Pharmacology
Nutrients | Free Full-Text | New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs) | HTML
New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes: ESC Working Group on Thrombosis—Task Force on Anticoagulants in Heart Disease Position Paper - ScienceDirect
Dabigatran, intracranial hemorrhage, and the neurosurgeon in: Neurosurgical Focus Volume 34 Issue 5 (2013) Journals
![PDF] New oral anticoagulant drugs - mechanisms of action | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9a9d56be58acb05d3a8b5170db88c44acde89c01/2-Figure1-1.png "PDF] New oral anticoagulant drugs - mechanisms of action | Semantic Scholar")
PDF] New oral anticoagulant drugs - mechanisms of action | Semantic Scholar
The new, direct, target-specific oral anticoagulants Kassim NA - J Appl Hematol
Idarucizumab Overview - Creative Biolabs
Anticoagulant - Wikipedia
REVISED Anticoagulation module 3: anticoagulant therapy - The British Journal of Cardiology
Medicines | Free Full-Text | Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update | HTML
Dabigatran: Review of Pharmacology and Management of Bleeding Complications of This Novel Oral Anticoagulant | SpringerLink
